Takiguchi Y - Search Results

1

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.

Hotta K, Hida T, Nokihara H, Morise M, Kim YH, Azuma K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Watanabe S, Goto K, Satouchi M, Kozuki T, Shukuya T, Nakagawa K, Mitsudomi T, Yamamoto N, Asakawa T, Yoshimoto T, Takata S, Tamura T. Hotta K, et al. Among authors: takiguchi y. ESMO Open. 2022 Aug;7(4):100527. doi: 10.1016/j.esmoop.2022.100527. Epub 2022 Jul 14. ESMO Open. 2022. PMID: 35843080 Free PMC article. Clinical Trial.

2

Thermoradiotherapy for local control of chest wall invasion in patients with advanced non-small cell lung cancer.

Sakao S, Takiguchi Y, Nemoto K, Tatsumi K, Tanabe N, Kurosu K, Ooiwa T, Shirasawa H, Kuriyama T. Sakao S, et al. Among authors: takiguchi y. Int J Clin Oncol. 2002 Dec;7(6):343-8. doi: 10.1007/s101470200052. Int J Clin Oncol. 2002. PMID: 12494249

3

Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma.

Takiguchi Y, Uruma R, Asaka-Amano Y, Kurosu K, Kasahara Y, Tanabe N, Tatsumi K, Uno T, Itoh H, Kuriyama T. Takiguchi Y, et al. Int J Clin Oncol. 2005 Dec;10(6):418-24. doi: 10.1007/s10147-005-0525-6. Int J Clin Oncol. 2005. PMID: 16369746 Clinical Trial.

4

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, Okamoto H, Ogura T, Yokoyama A, Seki N, Asaka-Amano Y, Harada M, Tagawa A, Kunikane H, Yokoba M, Uematsu K, Kuriyama T, Kuroiwa Y, Watanabe K; Thoracic Oncology Research Group Study 0301. Onoda S, et al. Among authors: takiguchi y. J Clin Oncol. 2006 Dec 1;24(34):5448-53. doi: 10.1200/JCO.2006.08.4145. J Clin Oncol. 2006. PMID: 17135647 Clinical Trial.

5

Phase II study of weekly irinotecan and cisplatin for refractory or recurrent non-small cell lung cancer.

Takiguchi Y, Moriya T, Asaka-Amano Y, Kawashima T, Kurosu K, Tada Y, Nagao K, Kuriyama T. Takiguchi Y, et al. Lung Cancer. 2007 Nov;58(2):253-9. doi: 10.1016/j.lungcan.2007.06.004. Epub 2007 Jul 20. Lung Cancer. 2007. PMID: 17658654 Clinical Trial.

6

Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer.

Takiguchi Y, Tada Y, Gemma A, Kudoh S, Hino M, Yoshimori K, Yoshimura A, Nagao K, Niitani H. Takiguchi Y, et al. Lung Cancer. 2010 Jun;68(3):409-14. doi: 10.1016/j.lungcan.2009.08.009. Epub 2009 Sep 8. Lung Cancer. 2010. PMID: 19740565 Clinical Trial.

7

Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.

Kobayashi H, Uno T, Isobe K, Ueno N, Watanabe M, Harada R, Takiguchi Y, Tatsumi K, Ito H. Kobayashi H, et al. Among authors: takiguchi y. Jpn J Clin Oncol. 2010 May;40(5):464-9. doi: 10.1093/jjco/hyp190. Epub 2010 Jan 18. Jpn J Clin Oncol. 2010. PMID: 20085905

8

Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502.

Seto T, Yamanaka T, Wasada I, Seki N, Okamoto H, Ogura T, Shibuya M, Takiguchi Y, Shinkai T, Masuda N, Ichinose Y, Eguchi K, Watanabe K. Seto T, et al. Among authors: takiguchi y. Lung Cancer. 2010 Aug;69(2):213-7. doi: 10.1016/j.lungcan.2009.10.017. Epub 2010 Feb 13. Lung Cancer. 2010. PMID: 20153912 Clinical Trial.

9

Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.

Takiguchi Y, Seto T, Ichinose Y, Nogami N, Shinkai T, Okamoto H, Minato K, Seki N, Eguchi K, Kishi K, Nishikawa M, Watanabe K. Takiguchi Y, et al. J Thorac Oncol. 2011 Jan;6(1):156-60. doi: 10.1097/JTO.0b013e3181f7c76a. J Thorac Oncol. 2011. PMID: 21107293 Free article. Clinical Trial.

10

Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer.

Takiguchi Y, Iwasawa S, Minato K, Miura Y, Gemma A, Noro R, Yoshimori K, Shingyoji M, Hino M, Ando M, Okamoto H. Takiguchi Y, et al. Int J Clin Oncol. 2015 Aug;20(4):659-67. doi: 10.1007/s10147-014-0755-6. Epub 2014 Oct 11. Int J Clin Oncol. 2015. PMID: 25301566 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters